X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.businesswire.com/news/home/20210616005316/en/Mirum-Pharmaceuticals-to-Showcase-Analyses-From-Its-Rare-Liver-Disease-Programs-at-The-International-Liver-Congress-2021
https://endpts.com/in-86m-ipo-pitch-mirum-spells-out-plans-to-turn-shire-discards-into-orphan-liver-drug-successes/
https://www.prnewswire.com/news-releases/mirum-pharmaceuticals-secures-120-million-in-series-a-financing-to-develop-phase-3-ready-maralixibat-for-rare-liver-diseases-300745243.html
http://www.pmlive.com/pharma_news/immunology_keeps_shire_figures_solid_as_takeda_takeover_nears_1246459
Market Place
Share 
